13183
To further characterize altered expression of TCRzeta , p56(lck) , and impaired activation of NFkappaB , T lymphocytes were obtained from 65 patients with RCC , the majority of whom were receiving combination cytokine therapy [ interleukin (IL)-2 , IFN alpha -containing regimens ] and 37 control individuals.
 ( protein: NFkappaB, None) , ( protein: interleukin (IL)-2, None) , ( cell type: T lymphocytes, None) , ( protein: p56(lck), None) , ( protein: IFN alpha, None) , ( protein: TCRzeta, None) , ( protein: cytokine, None) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: RNA,cell type,protein,cell line,DNA, Arguments type: . 
Text: {0} 
Answer:
 ( protein: NFkappaB, None) , ( protein: interleukin (IL)-2, None) , ( cell type: T lymphocytes, None) , ( protein: p56(lck), None) , ( protein: IFN alpha, None) , ( protein: TCRzeta, None) , ( protein: cytokine, None) 